Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.

Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ.

Am J Psychiatry. 2007 Aug;164(8):1189-97.

PMID:
17671281
2.

Income and attrition in the treatment of depression: a STAR*D report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH.

Depress Anxiety. 2009;26(7):622-33. doi: 10.1002/da.20541.

PMID:
19582825
3.

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.

Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH.

Depress Anxiety. 2009;26(7):612-21. doi: 10.1002/da.20568.

PMID:
19382183
4.

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH.

Int J Neuropsychopharmacol. 2009 May;12(4):459-73. doi: 10.1017/S1461145708009073. Epub 2008 Jul 9.

PMID:
18611293
5.

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team.

Am J Psychiatry. 2006 Jan;163(1):28-40.

PMID:
16390886
6.

Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray?

Murphy EJ, Kassem L, Chemerinski A, Rush AJ, Laje G, McMahon FJ.

Depress Anxiety. 2013 Nov;30(11):1137-44. doi: 10.1002/da.22134. Epub 2013 May 30.

7.

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.

Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ.

J Clin Psychiatry. 2008 Aug;69(8):1246-56.

PMID:
18681756
8.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
10.

Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW, Moutier C, Fava M, Wisniewski SR, Luther J, Rush AJ.

J Affect Disord. 2009 Sep;117(1-2):63-73. doi: 10.1016/j.jad.2009.01.002. Epub 2009 Feb 14.

PMID:
19217668
11.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
12.

Citalopram treatment of paroxetine-intolerant depressed patients.

Thase ME, Ferguson JM, Lydiard RB, Wilcox CS.

Depress Anxiety. 2002;16(3):128-33.

PMID:
12415538
13.

Medication augmentation after the failure of SSRIs for depression.

Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1243-52.

14.

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.

Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, McGrath PJ, Balasubramani GK, Warden D, Rush AJ.

Drug Alcohol Depend. 2010 Mar 1;107(2-3):161-70. doi: 10.1016/j.drugalcdep.2009.10.003. Epub 2009 Nov 28.

PMID:
19945804
15.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
16.

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Mohamed S, Osatuke K, Aslam M, Kasckow J.

Am J Geriatr Pharmacother. 2006 Sep;4(3):201-9.

PMID:
17062320
17.

Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, Lebowitz B, Zisook S, Rush AJ.

Am J Geriatr Psychiatry. 2008 Jan;16(1):58-64. doi: 10.1097/JGP.0b013e31815a43d7.

PMID:
18165462
18.

Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.

Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E.

Psychol Med. 2011 Oct;41(10):2089-97. doi: 10.1017/S0033291711000158. Epub 2011 Feb 25.

PMID:
21349239
19.

Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.

Mrazek DA, Biernacka JM, McAlpine DE, Benitez J, Karpyak VM, Williams MD, Hall-Flavin DK, Netzel PJ, Passov V, Rohland BM, Shinozaki G, Hoberg AA, Snyder KA, Drews MS, Skime MK, Sagen JA, Schaid DJ, Weinshilboum R, Katzelnick DJ.

J Clin Psychopharmacol. 2014 Jun;34(3):313-7. doi: 10.1097/JCP.0000000000000099. Erratum in: J Clin Psychopharmacol. 2014 Oct;34(5):558.

20.

Prognostic subgroups for citalopram response in the STAR*D trial.

Jakubovski E, Bloch MH.

J Clin Psychiatry. 2014 Jul;75(7):738-47. doi: 10.4088/JCP.13m08727.

Supplemental Content

Support Center